CytoDyn Announces First Patient Dosed in Expanded Access Program for Leronlimab in Triple-Negative Breast Cancer Apr 27, 2026 8:30am EDT
CytoDyn Presents New Leronlimab Data in Metastatic Colorectal Cancer at AACR Annual Meeting 2026 Apr 22, 2026 8:30am EDT
CytoDyn Presents New Leronlimab Data in Metastatic Triple-Negative Breast Cancer at AACR Annual Meeting 2026 Apr 20, 2026 8:30am EDT
CytoDyn Closes $17.5 Million Financing to Fund Continued Development of Leronlimab Mar 05, 2026 8:30am EST
CytoDyn Presents Novel CCR5 Inhibition Mechanisms and Long-Term Survival Signals for Leronlimab in Metastatic Breast Cancer at AACR Immuno-Oncology Conference Feb 20, 2026 8:30am EST
CytoDyn Announces Funding and Initiation of Expanded Access Program for Patients with Triple-negative Breast Cancer Jan 27, 2026 8:30am EST
